FLARE Study: Can Family Programs Improve Sun Safety in Children?
When a parent receives a skin cancer diagnosis, the reality of shared hereditary and environmental hazards often shifts the focus toward the next generation. Establishing consistent sun-protective habits early in life can significantly reduce long-term harm. In 2023, researchers detailed a specialized behavioral approach in a paper describing the Family Lifestyles, Actions and Risk Education trial, known as the FLARE study. This explainer examines the protocol, how family interventions operate, and what this research can tell us about cultivating protective habits.
Why Are Children of Melanoma Patients Given Special Consideration?
Children of parents who have had melanoma face a higher likelihood of developing skin cancer themselves because of shared familial risks. Both inherited biological traits and shared family habits contribute to this heightened risk profile. Because childhood sun exposure plays an influential role in future health, the prevention of sunburns and active promotion of sun-protective behaviors are considered essential steps to control cancer among these young individuals.
Navigating these risks involves practical, everyday adjustments rather than untested shortcuts or unregulated tanning products. Parents learning about living with melanoma frequently seek evidence-based ways to safeguard their households, which makes targeted prevention research particularly critical for high-risk families.
What Is the Design of the FLARE Study?
The FLARE trial was detailed in a 2023 design paper titled The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors in the journal Contemporary Clinical Trials. It is set up as a two-arm randomized controlled trial rather than an informal observational review.
The trial design centers on specific participant criteria:
- It recruits dyads composed of one parent who is a melanoma survivor and their child.
- Eligible children are aged 8 to 17 years.
- Participating dyads are randomized into one of two groups: the FLARE intervention arm or a standard skin cancer prevention education comparison arm.
- Both arms of the study entail 3 telehealth sessions conducted with an interventionist.
How Does the FLARE Behavioral Intervention Function?
Rather than relying purely on passive brochures, the FLARE curriculum applies established behavioral science principles. The intervention is guided by Social-Cognitive and Protection Motivation theories. Its goal is to influence daily habits through active collaboration between parent and child.
The program specifically targets child sun protection behaviors by addressing several key components:
- Perceived Risk: Examining both parent and child perceived risk for melanoma to build clear awareness of personal vulnerability.
- Problem-Solving Skills: Teaching families practical strategies to manage obstacles that typically disrupt daily defense routines.
- Family Action Planning: Creating a structured family skin protection action plan designed to foster positive modeling of sun safety habits by the parent.
By integrating parent-child modeling, the protocol aims to transform sun protection into a shared household routine rather than an isolated chore imposed only on the child. Further background on general pediatric skin safety can be found in our guide on protecting children and infants from sun exposure.
What Specific Outcomes Are Tracked in the Trial?
To determine whether the collaborative sessions yield measurable changes, the trial outlines a structured follow-up schedule. Participating parents and children complete surveys across multiple assessments extending through one-year post-baseline.
Researchers monitor several distinct markers of behavioral change:
- The frequency of reported child sunburns over time.
- Direct child sun protection behaviors used during daily activities.
- Melanin-induced surface skin color change, which serves as a physical indicator of ultraviolet exposure and tanning.
- Potential mediators of intervention effects, including the degree of parent-child modeling taking place in the home.
What Are the Limits of the 2023 Publication?
It is important to evaluate this research accurately without overstating its conclusions. The 2023 article in Contemporary Clinical Trials is a study protocol, meaning it details the study rationale, structure, and assessment plan rather than completed clinical trial results. While the authors note that FLARE could help mitigate familial melanoma risk if found efficacious, final conclusions depend on the completion of the trial and subsequent peer-reviewed findings.
The study is also restricted to a specific demographic group: melanoma survivors and their offspring aged 8 to 17 years. The findings from this specialized interventionist-led telehealth model may not directly translate to families without a history of melanoma or to independent health education outside a research setting. Families interested in assessing their genetic or personal skin cancer risks should always seek direct evaluation and personalized counseling from a qualified dermatologist or medical doctor.
Sources
Published October 30, 2026. Sources are linked in the text. See our Medical Disclaimer.